This multicenter registry study aims to understand the status of diagnosis and treatment, quality of life, medical costs and unmet medical needs of adult patients with chronic hypoparathyroidism in China.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The proportion of patients with different classification of hypoparathyroidism (HP)
Timeframe: 0 day (cross-sectional)
The proportion of patients with different symptoms of HP
Timeframe: 0 day (cross-sectional)
The proportion of patients with positive Chvostek sign
Timeframe: 0 day (cross-sectional)
The proportion of patients with positive Trousseau's sign
Timeframe: 0 day (cross-sectional)
The proportion of patients with abnormal corrected calcium
Timeframe: 0 day (cross-sectional)
The proportion of patients with abnormal parathyroid hormone (PTH)
Timeframe: 0 day (cross-sectional)
The proportion of patients with abnormal 24-hour urine calcium
Timeframe: 0 day (cross-sectional)
The proportion of patients with different first-visit reasons
Timeframe: 0 day (cross-sectional)
The proportion of patients with different first-visit departments
Timeframe: 0 day (cross-sectional)